Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse

Veterinary Immunology and Immunopathology

Volumn 111, Issue 1-2, 2006, Pages 59-66

  Weerasinghe, C U ^a   Learmonth, G S ^b   Gilkerson, J R ^c   Foote, C E ^a   Wellington, J E ^a   Whalley, J M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antibody responses; E. coli expression; Equine herpesvirus 1; Glycoprotein D; Mouse model

Indexed keywords

GLYCOPROTEIN D; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACULOVIRUS; CARBOXY TERMINAL SEQUENCE; COMPARATIVE STUDY; CONTROLLED STUDY; EQUINE HERPES VIRUS; ESCHERICHIA COLI; GLYCOSYLATION; HORSE; IMMUNOGENICITY; INOCULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; BLOTTING, WESTERN; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HORSE DISEASES; HORSES; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RESPIRATORY TRACT DISEASES; VIRAL ENVELOPE PROTEINS;

ANIMALIA; EQUID HERPESVIRUS 1; EQUIDAE; EQUUS CABALLUS; ESCHERICHIA COLI; INSECTA;

EID: 33646002071     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.01.009     Document Type: Article

References (30)

1. Allen G.P., Kydd J.H., Slater J.D., and Smith K.C. Advances in understanding of the pathogenesis, epidemiology and immunological control of equine herpesvirus abortion. In: Wernery U., Wade J.F., Mumford J.A., and Kaaden O.R. (Eds). Equine Infectious Diseases vol. VIII (1999), R & W Publications Ltd., Newmarket 129-146
2. Audonnet J.C., Mumford J.A., Jessett D., Pardo M.C., Taylor J., Tartaglia J., and Minke J.M. Safety and efficacy of a canarypox-EHV-recombinant vaccine in horses. Equine Infectious Diseases vol. VIII (1999), R & W Publications Ltd., Newmarket pp. 418-419
3. Awan A.R., Chong Y.C., and Field H.J. The pathogenesis of equine herpesvirus 310 type 1 in the mouse: a new model for studying host responses to the infection. J. Gen. Virol. 71 (1990) 1131-1140
4. Connolly S.A., Landsburg D.J., Carfi A., Wiley D.C., Cohen G.H., and Eisenberg R.J. Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface. J. Virol. 77 (2003) 8127-8140
5. Crabb B.S., Macpherson C.M., Reubel G.H., Browning G.F., Studdert M.J., and Drummer H.E. A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Arch. Virol. 140 (1995) 245-258
6. Csellner H., Whalley J.M., and Love D.N. Equine herpesvirus-1 HVS25A isolated from an aborted foetus produces disease in BALB/c mice. Aust. Vet. J. 72 (1995) 68-69
7. Csellner H., Walker C., Wellington J.E., McLure L.E., Love D.N., and Whalley J.M. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice. Arch. Virol. 145 (2000) 2371-2385
8. Flowers C.C., and O'Callaghan D.J. Equine herpesvirus-1 glycoprotein-D mapping of the transcript and a neutralization epitope. J. Virol. 66 (1992) 6451-6460
9. Foote C.E., Love D.N., Gilkerson J.R., Rota J., Trevor-Jones P., Ruitenberg K.M., Wellington J.E., and Whalley J.M. Serum antibody responses to equine 330 herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals. Vet. Immunol. Immunopathol. 105 (2005) 47-57
10. Johnson D.L., Middleton S.A., McMahon F., Barbone F.P., Kroon D., Tsao E., Lee W.H., Mulcahy L.S., and Jolliffe L.K. Refolding, purification, and characterization of human erythropoietin binding protein produced in Escherichia coli. Protein Exp. Purif. 7 (1996) 104-113
11. Love D.N., Bell C.W., and Whalley J.M. Characterization of the glycoprotein-D gene products of equine herpesvirus-1 using a prokaryotic cell expression vector. Vet. Microbiol. 30 (1992) 387-394
12. Love D.N., Bell C.W., Pye D., Edwards S., Hayden M., Lawrence G.L., Boyle D., Pye T., and Whalley J.M. Expression of equine herpesvirus-1 glycoprotein-D by using a recombinant baculovirus. J. Virol. 67 (1993) 6820-6823
13. Ruitenberg K.M., Walker C., Wellington J.E., Love D.N., and Whalley J.M. DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection. Vaccine 17 (1999) 237-244
14. Ruitenberg K.M., Walker C., Wellington J.E., Love D.N., and Whalley J.M. Potential of DNA-mediated vaccination for equine herpesvirus 1. Vet. Microbiol. 68 (1999) 35-48
15. Ruitenberg K.M., Love D.N., Gilkerson J.R., Wellington J.E., and Whalley J.M. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody. Vet. Microbiol. 76 (2000) 117-127
16. Ruitenberg K.M., Walker C., Love D.N., Wellington J.E., and Whalley J.M. A prime-boost immunization strategy with DNA and recombinant baculovirus expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naive and infection-primed mice. Vaccine 18 (2000) 1367-1373
17. Ruitenberg K.M., Gilkerson J.R., Wellington J.E., Love D.N., and Whalley J.M. Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is 360 hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease. Virus Res. 79 (2001) 125-135
18. Soboll G., Whalley J.M., Koen M.T., Allen G.P., Fraser D.G., Macklin M.D., Swain W.F., and Lunn D.P. Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes. J. Gen. Virol. 84 (2003) 2625-2634
19. Stokes A., Allen G.P., Pullen L.A., and Murray P.K. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18. J. Gen. Virol. 70 (1989) 1173-1183
20. Stokes A., Cameron R.S., Marshall R.N., and Killington R.A. High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2K(k)) murine model. Virus Res. 50 (1997) 159-173
21. Telford E.A.R., Watson M.S., McBride K., and Davison A.J. The DNA sequence of equine herpesvirus 1. Virology 189 (1992) 304-316
22. Tewari D., Whalley J.M., Love D.N., and Field H.J. Characterization of immune responses to baculovirus expressed equine herpesvirus type 1 glycoprotein D and glycoprotein H in a murine model. J. Gen. Virol. 75 (1994) 1735-1741
23. Walker C., Love D.N., and Whalley J.M. Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse 380 model: a review. Vet. Microbiol. 68 (1999) 3-13
24. Walker C., Ruitenberg K.M., Love D.N., and Whalley J.M. Immunization of BALB/c mice with DNA encoding equine herpesvirus 1 (EHV-1) glycoprotein D affords partial protection in a model of EHV-1-induced abortion. Vet. Microbiol. 76 (2000) 211-220
25. Wellington J.E., Lawrence G.L., Love D.N., and Whalley J.M. Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines. Arch. Virol. 141 (1996) 1785-1793
26. Wellington J.E., Gooley A.A., Love D.N., and Whalley J.M. N-terminal sequence analysis of equine herpesvirus 1 glycoproteins D and B and evidence 390 for internal cleavage of the gene 71 product. J. Gen. Virol. 77 (1996) 75-82
27. Whalley J.M., Robertson G.R., and Davison A.J. Analysis of the genome of equine herpesvirus type 1: arrangement of cleavage sites for restriction endonucleases EcoRI, BglII, and BamHI. J. Gen. Virol. 57 (1981) 307-323
28. Whittaker G.R., Taylor L.A., Elton D.M., Giles L.E., Bonass W.A., Halliburton I.W., Killington R.A., and Meredith D.M. Glycoprotein-60 of equine herpesvirus type-1 is a homologue of herpes simplex virus glycoprotein-D and plays a major role in penetration of cells. J. Gen. Virol. 73 (1992) 801-809
29. Zhang Y.F., Smith P.M., Tarbet E.B., Osterrieder N., Jennings S.R., and O'Callaghan D.J. Protective immunity against equine herpesvirus type-1 (EHV-1) 400 infection in mice induced by recombinant EHV-1 gD. Virus Res. 56 (1998) 11-24
30. Zhang Y.F., Smith P.M., Jennings S.R., and O'Callaghan D.J. Quantitation of virus-specific classes of antibodies following immunization of mice with attenuated equine herpesvirus 1 and viral glycoprotein D. Virology 268 (2000) 482-492